Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding

Molecular Pharmaceutics

Volumn 4, Issue 3, 2007, Pages 347-354

  Karki, Shyam ^a   Friščić, Tomislav ^a   Jones, William ^a   Motherwell, W D Samuel ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE   (United Kingdom)

Author keywords

Hydrate; Liquid assisted grinding; Neat grinding; Pharmaceutical cocrystal

Indexed keywords

CAFFEINE CITRATE; CITRIC ACID; CRYSTALLIN; THEOPHYLLINE; WATER;

ARTICLE; CRYSTAL STRUCTURE; DRUG SCREENING; DRUG STABILITY; HYDRATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; X RAY POWDER DIFFRACTION;

CAFFEINE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG STABILITY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; POWDER DIFFRACTION; THEOPHYLLINE; WATER;

EID: 34250864401     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0700054     Document Type: Article

References (33)

1. Aakeröy, C. B.; Salmon, D. J. Building co-crystals with molecular sense and supramolecular sensibility. CrystEngComm 2005, 7, 439-448.
2. Vishweshwar, P.; McMahon, J. A.; Peterson, M. L.; Hickey, M. B.; Shattock, T. R.; Zaworotko, M. J. Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients. Chem. Commun. 2005, 4601-4603.
3. Sokolov, A. N.; Friščić, T.; MacGillivray, L. R. Enforced Face-to-Face Stacking of Organic Semiconductor Building Blocks within Hydrogen-Bonded Molecular Cocrystals. J. Am. Chem. Soc. 2006, 128, 2806-2807.
4. Friscic, T.; MacGillivray, L. R.. Reversing the code of a template-directed solid-state synthesis: a bipyridine template that directs a single-crystal-to-single-crystal [2+2] photodimerisation of a dicarboxylic acid. Chem. Commun. 2005, 5748-5750.
5. Friščić, T.; MacGillivray, L. R. Modularity in organic solid state and supramolecular chemistry. Croat. Chem. Acta 2006, 79, 327-333.
6. Aakeröy, C. B.; Beatty, A. M.; Helfrich, B. A. "Total synthesis" supramolecular style: design and hydrogen-bond-directed assembly of ternary supermolecules. Angew. Chem., Int. Ed. 2001, 40, 3240-3242.
7. McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M. S.; Mannion, R.; O'Donnel, E.; Park, A. Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API. Pharm. Res. 2006, 23, 1888-1897.
8. Nehm, S. J.; Rodriguez-Spong, B.; Rodriguez-Hornedo, N. Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation. Cryst. Growth Des. 2006, 6, 592-600.
9. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Physical stability enhancement of theophylline via cocrystallization. Int. J. Pharm. 2006, 320, 114-123.
10. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration. Cryst. Growth Des. 2005, 5, 1013-1021.
11. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. Pharmaceutical co-crystals. J. Pharm. Sci. 2006, 95, 499-516.
12. Shaameri, Z.; Jones, W. Molecular complexes between 2,2′- biphenyldicarboxylic acid and phenazine: anhydrous and hydrated forms. Mol. Cryst. Liq. Cryst. 2001, 356, 131-142.
13. Trask, A. V.; Jones, W. Crystal engineering of organic cocrystals by the solid-state grinding approach. Top. Curr. Chem. 2005, 254, 41-70.
14. Batchelor, E.; Klinowski, J.; Jones, W. Crystal engineering using co-crystallisation of phenazine with dicarboxylic acids. J. Mater. Chem. 2000, 10, 839-848.
15. Jayasankar, A.; Somwangthanaroj, A.; Shao, Z. J.; Rodriguez-Hornedo, N. Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase. Pharm. Res. 2006, 23, 2381-2392.
16. Friščić, T.; Fábián, L.; Burley, J. C.; Jones, W.; Motherwell, W. D. S. Exploring cocrystal-cocrystal reactivity via liquid-assisted grinding: assembling of racemic and dismantling of enantiomeric cocrystals. Chem. Commun. 2006, 5009-5011.
17. Friǧčić;, T.; Trask, A. V.; Jones, W.; Motherwell, W. D. S. Screening for Inclusion Compeounds and Systematic Construction of Three-Component Solids by Liquid-Assisted Grinding. Angew. Chem., Int. Ed. 2006, 45, 7546-7550.
18. A search of the 2006 Cambridge Structural Database (version 5.27) for structures of organic compounds of citric acid revealed three structures, CCDC reference codes: CITARC, CITRAC10, XOB-HIF.
19. Melia, T. P. Dissociation pressures of citric acid monohydrate. Trans. Faraday Soc. 1964, 60, 1286-1288.
20. Chappel, F. P.; Hoare, F. E. Heat of combustion of citric acid monohydrate. Trans. Faraday Soc. 1958, 54, 367-371.
21. The cocrystal of caffeine and citric acid is probably the "caffeine citrate" used in treatment of apnea: Bhatia, J. Current options in the management of apnea of prematurity. Clin. Pediatr. 2000, 39, 327-336.
22. Shan, N.; Jones, W. Identification of supramolecular templates: design of solid-state photoreactivity using structural similarity. Tetrahedron Lett. 2003, 44, 3687-3689.
23. Shan, N.; Bond, A. D.; Jones, W. Crystal engineering using 4,4′-bipyridyl with di- and tricarboxylic acids. Cryst. Eng. 2002, 5, 9-24.
24. The mechanochemical formation of caffeine and theophylline hydrates has been previously reported during wet granulation of corresponding anhydrates: Jorgensen, A.; Rantanen, J.; Karjalainen, M.; Khriachtchev, L.; Raesaenen, E.; Ylirousi, J. Hydrate Formation During Wet Granulation Studied by Spectroscopic Methods and Multivariate Analysis. Pharm. Res. 2002, 19, 1285-1291.
25. Edwards, H. G. M.; Lawson, E.; de Matas, M.; Shields, L.; York, P. Metamorphosis of caffeine hydrate and anhydrous caffeine. J. Chem. Soc., Perkin Trans. 1997, 2, 1985-1990.
26. Sun, C.; Zhou, D.; Grant, D. J. W.; Young, V. G., Jr. Theophylline monohydrate. Acta Crystallogr. 2002, E58, o368-o370. CCDC reference code: THEOPH01.
27. 2O. Cryst. Struct. Commun. 1972, 1, 23-6. CCDC reference code: CITARC.
28. Glusker, J. P; Minkin, J. A.; Patterson, A. L. X-ray crystal analysis of the substrates of aconitase. IX. A refinement of the structure of anhydrous citric acid. Acta Crystallogr. 1969, B25, 1066-1072. CCDC reference code: CITRAC10.
29. Inspection of PXRD patterns reveals that neat grinding of anhydrous caffeine (β-form) with citric acid resulted in a partial conversion to α-caffeine.
30. Exposure of 3 to 98% relative humidity conditions results in the formation of a sticky solid. Inspection of the solid using XRPD reveals the presence of only solid caffeine hydrate, suggesting that citric acid is contained in the liquid phase.
31. For the only previous example where caffeine acts as a 3-fold hydrogen bond acceptor toward OH donors, see: Martin, R.; Lilley, T. H.; Bailey, N. A.; Falshaw, C. P.; Haslam, E.; Magnolato, D.; Begley, M. J. Polyphenol-Caffeine Complexation. Chem. Commun. 1986, 105-106. CCDC reference code: DIJWAU.
32. The formation of cocrystal hydrates by crystallization from solution has previously been observed; see: Zaitu, S.; Miwa, Y.; Taga, T. A 2:1 Molecular Complex of Theophylline and 5-Fluorouracil as the Monohydrate. Acta Crystallogr. 1995, C51, 1857-1859. CCDC reference code: ZAYLOA
33. Ticehurst, M. D.; Storey, R. A.; Watt, C. Application of Slurry Bridging Experiments at Controlled Water Activities to Predict the Solid-State Conversion between Anhydrous and Hydrated Forms Using Theophylline as a Model Drug. Int. J. Pharm. 2002, 247, 1-10.